These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immunology of the mouse mammary tumor virus: comparison of mammary tumor virus with the agent found in C3Hf/Crgl mice. Blair PB; Weiss DW J Natl Cancer Inst; 1966 Mar; 36(3):423-9. PubMed ID: 18630318 [TBL] [Abstract][Full Text] [Related]
7. Tolerance induction and sensitization by preincubation of bone marrow with allogeneic erythrocytes. Uphoff DE J Natl Cancer Inst; 1971 Dec; 47(6):1223-31. PubMed ID: 4399195 [No Abstract] [Full Text] [Related]
8. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells. Ritzi EM; Smith BA; Stolfi RL; Martin DS Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731 [TBL] [Abstract][Full Text] [Related]
9. Antilymphoid globulin in the therapy of secondary disease. Corneci I; Andrian T; Costachel O; Feteanu A Transplant Proc; 1971 Mar; 3(1):422-6. PubMed ID: 4398500 [No Abstract] [Full Text] [Related]
10. Immune status of allogeneic radiation chimeras. Gengozian N; Congdon CC; Allen EA; Toya RE Transplant Proc; 1971 Mar; 3(1):434-6. PubMed ID: 4398502 [No Abstract] [Full Text] [Related]
11. Transient graft-versus-host reaction in the treatment of leukemia in mice. Boranić M J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445 [No Abstract] [Full Text] [Related]
12. Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation. Miconnet I; de La Selle V; Bruley-Rosset M Bone Marrow Transplant; 1998 Mar; 21(6):583-90. PubMed ID: 9543062 [TBL] [Abstract][Full Text] [Related]
13. [Induction of histoimmune shock in the transplantation of heterologous splenic cells and bone marrow]. Shevelev AS; Semenkov VF; Fedosov EA; Stysina EE; Fomina AA Biull Eksp Biol Med; 1966 Feb; 61(2):68-71. PubMed ID: 4882188 [No Abstract] [Full Text] [Related]
14. Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system. Vaage J; Medina D Cancer Res; 1974 Jun; 34(6):1319-24. PubMed ID: 4363654 [No Abstract] [Full Text] [Related]
15. Reduced secondary disease mortality in mouse radiation chimeras. Congdon CC; Gardiner DA; Kastenbaum MA J Natl Cancer Inst; 1967 Apr; 38(4):541-8. PubMed ID: 5337672 [No Abstract] [Full Text] [Related]
19. [Myelo-restorative capacities and immunocompetence of bone marrow cells of the mouse cultivated in vitro. Action of phytohemagglutinin (PHA)]. Halpern B; Liacopoulos-Briot M; Crepin Y; Lambert F; Martial-Lasfargues C Ann Inst Pasteur (Paris); 1970 Jul; 119(1):87-99. PubMed ID: 4915934 [No Abstract] [Full Text] [Related]
20. Two distinct types of late onset graft-versus-host disease after bone marrow transplantation in lethally irradiated mice. Heidt PJ; Wagemaker G; Knaan-Shanzer S; van Bekkum DW Transplantation; 1981 Sep; 32(3):263-4. PubMed ID: 7025379 [No Abstract] [Full Text] [Related] [Next] [New Search]